ARCHIVES

Retraction Based On Data Given To Duke Last November, But Apparently Disregarded

This article is from The Cancer Letter archive.

Vol. 36 No. 39 | October 29, 2010

Download PDF Visit The Full Archive

Related Articles

A Low-Cost Vaccine To Enter Clinical Trials In A Year

September 24, 2010

ODAC Supports Approval For Taxotere In Breast Cancer, Hycamtin In Lung Cancer

June 5, 1998

Drugs and Targets: Blincyto granted accelerated approval in R/R ALL

December 5, 2014

In Brief: Groups agree On Mammography Screening: Money Bill Markups Due After July 4 Recess

June 23, 1989

Phase II Study of Veliparib Improves PFS by 35 Percent

October 31, 2014

Senate Votes Down Attempt to Cut NCI Funds $100 Million

October 3, 1975